Annual Securities Report — FY2025
What CAWACHI LIMITED reported for the period from 2025-03-16 to 2026-03-15. Filed by 株式会社カワチ薬品
Filed 2026-06-10View the original on EDINET
How much it says
33Thin
What moved here
9named for the first time
Its own wording
41terms
Which filing this is
37/ 37newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the fiscal year, the company opened 6 new stores, including 4 with attached pharmacies, and made related capital expenditures totaling ¥4,516 million. Revenue was ¥284,492 million, down 1.2% year on year. Net income attributable to owners of the parent was ¥3.2 billion, down 34.5% year on year, mainly due to the recognition of impairment losses.
Komori's summary of this document, not the document's own words.33Thin
How much this filing saysA weighted roll-up of 12 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
64
Detailed
45
Typical
54
Typical
62
Detailed
0
Almost nothing
0
Almost nothing
0
Almost nothing
0
Almost nothing
69
Detailed
7
Almost nothing
11
Almost nothing
73
Detailed
R&D spendNot disclosedThis document does not carry the figure.
Cash left over37億円Cash from the business, less what went into equipment.
Spent on equipment45億円Plants, machines — things meant to last.
Employees2,564Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.